Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DR-3355 injection in patients with gynecological infection
jRCT2080221815Phase 3
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of levofloxacin in intraamniotic infection (IAI), adnexitis and Pelviabdominal infection, sponsored by Daiichi Sankyo Co., Ltd.
02
Drugs
levofloxacin
03
Conditions
intraamniotic infection (IAI)adnexitisPelviabdominal infection
Beyond the preview
Go deeper on jRCT2080221815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221815.